address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,52WeekChange,SandP52WeekChange,quoteType,currentPrice,recommendationKey,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,longName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,exchangeTimezoneName,corporateActions,regularMarketPrice,regularMarketChangePercent,regularMarketTime,marketState,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,exchange,messageBoardId,trailingPegRatio
Bryggargatan 10,Stockholm,111 21,Sweden,46 7 62 19 37 38,https://www.ibtherapeutics.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Infant Bacterial Therapeutics AB (publ) operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, which is in Phase III clinical studies to prevent necrotizing enterocolitis, as well as to improve feeding tolerance in premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe birth abnormality in infants. In addition, its drug candidates include IBP-1118 to prevent retinopathy of prematurity that causes blindness in premature babies; and IBP-1122, indicated to eliminate vancomycin resistant enterococci that cause antibiotic resistant hospital infections. The company was incorporated in 2011 and is based in Stockholm, Sweden.",8,"[{'maxAge': 1, 'name': 'Mr. Staffan  Stromberg Ph.D.', 'age': 57, 'title': 'Chief Executive Officer', 'yearBorn': 1967, 'fiscalYear': 2024, 'totalPay': 6057000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Maria  Ekdahl', 'age': 51, 'title': 'Chief Financial Officer', 'yearBorn': 1973, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anders  Kronstr√∂m M.B.A., M.S.', 'age': 57, 'title': 'Chief Operating Officer', 'yearBorn': 1967, 'fiscalYear': 2024, 'totalPay': 500000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Thomas J. Schnitzer M.D., Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sanjiv  Sharma M.B.A.', 'age': 68, 'title': 'Head of Medical Affairs', 'yearBorn': 1956, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Jonas  Rastad M.D., Ph.D.', 'age': 74, 'title': 'Chief Medical Officer', 'yearBorn': 1950, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,2,48.1,48.1,47.2,49.0,48.1,48.1,47.2,49.0,0.0,0.452,634,634,14359,6862,6862,48.1,49.0,0,0,660098624,21.7,135.0,-660098.6,56.362,45.7905,0.0,0.0,SEK,False,468341568,0.0,11075797,13018100,0.17558001,0.47184,13471400,11.396,4.299754,1735603200,1767139200,1743379200,-125829000,-9.34,-468341.6,-0.5121704,0.1185931,EQUITY,49.0,none,191758000,14.234,0,3.561,3.662,-1000,-0.0,-0.29868,-0.58408,-1000,-77194624,-116344000,0.0,0.0,133041.0,SEK,IBT-B.ST,en-US,US,Equity,Free Realtime Quote,True,HIGH,Infant Bacterial Therapeutics A,Infant Bacterial Therapeutics AB (publ),CEST,7200000,se_market,False,Europe/Stockholm,[],49.0,1.8711051,1751529889,REGULAR,-7.3619995,-0.13061991,3.2094994,0.07009094,15,0,False,False,1459234800000,0.9000015,47.2 - 49.0,Stockholm,14359,27.3,1.2580644,21.7 - 135.0,-86.0,-0.63703704,-51.217037,1755669600,1755669600,1755669600,False,-9.34,STO,finmb_325472579,
